研究キーワード (3件)：
Esophageal cancer
, Hepatocellular carcinoma
, Molecular oncology
競争的資金等の研究課題 (6件)：
2022 - 2025 食道扁平上皮癌がん幹細胞における免疫逃避機構の解明
2018 - 2021 治療抵抗性解除による食道扁平上皮癌新規治療法の開発
2015 - 2018 FGF受容体阻害剤を用いた食道扁平上皮癌幹細胞を標的とした新規治療法の開発
2014 - 2017 食道癌三次元培養モデルを用いた癌幹細胞ニッチの解析
2013 - 2015 膵癌幹細胞の病理学的性質を規定するマイクロRNA機構の解明
2013 - 2015 食道扁平上皮癌幹細胞を標的とした新規治療法の開発
全件表示
論文 (105件)：
Risako Kohya, Goki Suda, Masatsugu Ohara, Takashi Sasaki, Tomoka Yoda, Naofumi Sakurai, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, et al. Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023. 15. 12
Takashi Sasaki, Goki Suda, Masatsugu Ohara, Shunichi Hosoda, Naoki Kawagishi, Risako Kohya, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Sonoe Yoshida, et al. Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
Shunichi Hosoda, Goki Suda, Takuya Sho, Koji Ogawa, Megumi Kimura, Zijian Yang, Sonoe Yoshida, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, et al. Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment. Liver cancer. 2023. 12. 2. 156-170
Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Akinori Kubo, et al. Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight. Hepatology research : the official journal of the Japan Society of Hepatology. 2023. 53. 7. 595-606
Zijian Yang, Goki Suda, Osamu Maehara, Masatsugu Ohara, Tomoka Yoda, Takashi Sasaki, Risako Kohya, Sonoe Yoshida, Shunichi Hosoda, Yoshimasa Tokuchi, et al. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023. 15. 3
Koji Tanaka, Kelly A. Whelan, Naryan L. Rustgi, Prasanna M. Chandramouleeswaran, Seiji Naganuma, Shingo Kagawa, Mitsuteru Natsuizaka, Yoshiaki Kita, Shoji Natsugoe, Que Jianwen, et al. Notch1 regulates epithelial-mesenchymal transition and tumor-initiating capability in esophageal squamous-cell carcinoma. CANCER RESEARCH. 2016. 76
